Title
Category
Credits
Event date
Cost
Responsible and Effective Opioid Prescribing
  • Prescribing: Opioid(s)
  • Pharmacology
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC
$21.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.
Controlled Substances and Substance Abuse: Best Practices for the Healthcare Professional
  • Drug Diversion
  • Prescribing: Controlled Substance(s)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC
$19.00
Learn safe and effective prescription of controlled substances, best-practices, and prevention methods for drug misuse in this course.
Prescription Drug and Controlled Substance Abuse: Opioid Diversion and Best-Practice Prescribing
  • Drug Diversion
  • Prescribing: Controlled Substance(s)
  • 3.00 ANCC
$30.00
This 3-contact-hour continuing education course shows nurses and other healthcare practitioners how prescription drug abuse can be prevented and why it is so common. Learn more about the current opioid and prescribed drug abuse epidemic and challenges in managing chronic pain for a better patient outcome.Meets Florida, Massachusetts, Nevada, New Jersey, Rhode Island and Texas requirements.
Best-Practice Prescribing and Drug Diversion Training for West Virginia Nurses (3 Hours)
  • Drug Diversion
  • Pharmacology
  • 3.00 ANCC
$30.00
MANDATORY WEST VIRGINIA NURSING CEU. Fulfills the WV Board of Nursing requirement of 3 contact hours of continuing education on drug diversion and responsible prescribing of controlled substances. Per Chapter 30-1-7a, each nurse must complete 3 contact hours initially and then 1 contact hour, thereafter, annually of CE for drug diversion training, best-practice prescribing of controlled substances training and training on prescribing and administration of an opioid antagonist if they prescribe, administer or dispense controlled substances.
Health 2.0: Implications for Care
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC
  • 3.00 ASWB
$21.00
This course will provide an overview of Web 2.0 and how it is used in the health, social work, and mental health fields, referred to as Health 2.0. It will also explore how Health 2.0 affects access to health information and ultimately clients' healthcare decisions. Internet health information seeking patterns and practitioners' and clients' perceptions of the Internet as a source of health information will also be discussed.
Buprenorphine for Opioid Use Disorder
  • Buprenorphine
  • Opioid Use Disorder (OUD)
  • 2.00 AMA PRA Category 1 Credit™
$0.00
The United States is in the midst of an epidemic of opioid overdoses and overdose deaths. Multiple factors have contributed to this epidemic. “One aspect of managing this crisis is to increase the number of providers able to treat opioid use disorder with Medication for Addiction Treatment (or MAT).”This presentation will focus on the use of buprenorphine to treat opioid use disorder. The purpose of the program is to educate potential buprenorphine prescribers to encourage them to treat patients with opioid use disorder with buprenorphine.
Disrupting Bias in Healthcare
  • Implicit Bias
  • 1.00 AMA PRA Category 1 Credit™
$0.00
Implicit biases and microaggressions have been shown to impact healthcare in many areas including contributing to (1) inaccurate or compromised clinical assessments, (2) differences in treatment recommendations (3) differences in communication quality with patients and (3) erosion of trust between health professionals and patients.  Though they have a potentially dangerous and long-lasting impact on healthcare, research has demonstrated that impact of implicit bias can be mitigated with awareness, concern of impact, and intentionality for change.
Antiviral Selection and Management of Potential Drug-Drug Interactions for COVID-19 in an Outpatient Setting
  • Pharmacology
  • 0.70 AANP Contact Hours
  • 0.70 AANP Pharmacology Contact Hours
  • 0.75 AMA PRA Category 1 Credit™
$0.00
Enhance your knowledge of COVID-19 management for non-hospitalized patients with this comprehensive Q&A. Expert faculty have answered important questions on guideline recommendations for pharmacologic treatments and provided essential insights for navigating potential drug-drug interactions. Add this direct and practical resource to your clinical toolbox and feel equipped to treat COVID-19 in the outpatient setting. 
Gender Affirming Hormonal Care for the Primary Care Provider
  • Pharmacology
  • Gender-affirming Care
  • LGBTQ
  • 1.00 AANP Contact Hours
  • 1.00 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This engaging session explores primary care for gender-diverse individuals. Through practical case studies, clinicians will navigate gender-affirming hormone therapies (GAHTs), including the benefits, complications, and comprehensive care strategies for patients. Enhance your expertise in supporting diverse patient populations.
Women’s Health/GI Issues
  • 0.75 AMA PRA Category 1 Credit™
$0.00
In this session, GI issues in women are discussed, including common duct dilemmas, primary biliary cholangitis, an approach to treating fecal incontinence, and an algorithm for treating chronic constipation.

Pages